http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3787644-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7ac65443e6c395094f391f6279c8336
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-08
filingDate 2019-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe22cf85ba58755d04796a503cde90f
publicationDate 2021-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3787644-A1
titleOfInvention Eye treatments employing serum from whole blood
abstract Eye drops for treating dry eye include serum extracted from whole blood. An example method includes collecting whole blood from one or more donors ( e.g. , allogenic whole blood); separating the whole blood to obtain a serum; applying radiation to the serum for viral inactivation; and adding one or more additives to the serum to produce eye drops.
priorityDate 2018-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417230
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395655

Total number of triples: 23.